S.H. Goey

Publications by Year

Research Areas

Immunotherapy and Immune Responses, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research

Most-Cited Works

• → Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.(1998)199 cited
• → Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.(1997)196 cited
• → Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal Antibody(1995)191 cited
• → The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study(2005)134 cited
• Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study.(1992)
• → Phase II to III Study Comparing Doxorubicin and Docetaxel With Fluorouracil, Doxorubicin, and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre(2005)102 cited
• → The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer(2015)63 cited
• → Interleukin-2 and Interferon-α in the Treatment of Patients with Advanced Non-Small-Cell Lung Cancer(1992)56 cited
• → Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication(1994)55 cited
• Duodenal metastasis: an uncommon cause of occult small intestinal bleeding.(2004)